TREE NEWS reports: Moderna’s stock more than doubled after a Phase 3 trial showed its cancer vaccine outperformed the standard of care, causing short sellers to lose $4.8 billion. This is a major milestone for the biotech sector, but it is not related to crypto or RWA.
Moderna Stock Surges on Cancer Vaccine Breakthrough
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1m ago
Onsemi in Talks to Acquire Startup Ferric for About $1B
4m ago
Korea Exchange Triggers SIDECAR, Halts KOSPI Program Trading
9m ago
Shanghai, Shenzhen margin balances fall 16.06B yuan to 2.37T
16m ago
SK Hynix Says DRAM and HBM Output Through 2029 Fully Sold Out
18m ago
SK Hynix Says Its Stock Is Undervalued
41m ago
Seoul Composite Index extends gains to 3%